I made a house call on an 90 year old patient yesterday. He lives with his wife in an idyllic house surrounded by vernal gardens and a wetland preserve.
Postscript: A week after I saw him, he had a PET scan. The next day, he developed profound weakness. He took to his bed. Stopped eating and drinking. He became stuporous and died two days after the scan attended to by his loving wife and a caring nurse. The day after he died, his oncologist called with the PET scan results. His liver was entirely replaced with tumor. He told her that Ketruda was not indicated in such a situation. He lived reasonably well until two weeks before he died.
1. Few people actually benefit from ‘breakthrough’ cancer immunotherapy
By and . March 8, 2017. Stat Topics. [We will try to see if the authors still believe this]
2. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. JAMA Netw. 2019 May 3;2(5):e192535. Free Full Text at PMC.